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Abstract
Background: Cerebral malaria (CM) and severe malarial anemia (SMA) are the most serious life-threatening clinical
syndromes of Plasmodium falciparum infection in childhood. Therefore it is important to understand the pathology
underlying the development of CM and SMA, as opposed to uncomplicated malaria (UM). Different host responses to
infection are likely to be reflected in plasma proteome-patterns that associate with clinical status and therefore provide
indicators of the pathogenesis of these syndromes.
Methods and Findings: Plasma and comprehensive clinical data for discovery and validation cohorts were obtained as part
of a prospective case-control study of severe childhood malaria at the main tertiary hospital of the city of Ibadan, an urban
and densely populated holoendemic malaria area in Nigeria. A total of 946 children participated in this study. Plasma was
subjected to high-throughput proteomic profiling. Statistical pattern-recognition methods were used to find proteome-
patterns that defined disease groups. Plasma proteome-patterns accurately distinguished children with CM and with SMA
from those with UM, and from healthy or severely ill malaria-negative children.
Conclusions:We report that an accurate definition of the major childhood malaria syndromes can be achieved using plasma
proteome-patterns. Our proteomic data can be exploited to understand the pathogenesis of the different childhood severe
malaria syndromes.
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Introduction
Human malaria caused by Plasmodium falciparum has an
estimated annual global disease burden of 300 million clinical
episodes, leading to one million deaths[1–4]. Eighty-five per cent
of the cases and 90% of the mortality occurs in sub-Saharan
Africa, mostly amongst children [5,6]. Recent reports point to
a reduction of malaria cases in parts of Africa [7]. However,
Nigeria, the most populous country of Africa, accounts for
a quarter of the global cases and a third of the malaria-attributable
childhood deaths [2,8,9].
Cerebral malaria (CM) and severe malarial anemia (SMA) are
the major severe disease syndromes in African children with a high
level of mortality in the under-five age group. The current WHO
case definitions for severe malaria combine P. falciparum blood
stage parasitemia with coma, severe anemia or respiratory distress
[10], and it is well documented that there is significant overlap
across these syndromes [11]. Despite the fact that these WHO case
definitions are sensitive and useful for clinical diagnosis, the
pathogenesis of severe disease is not well understood. One
disadvantage of the WHO clinical definitions is that they lack
the specificity required to carry out studies aimed at understanding
the pathogenesis of clinically different forms of childhood malaria.
Previous studies have attempted to define malaria syndromes by
studying plasma correlates of severity using reductionist ap-
proaches with variable success[12–14]. Small sample sizes, a lack
of validation cohorts and a focus on a small selection of host
plasma proteins have limited these studies. To overcome such
limitations we use a systems approach to define the plasma
proteome profile during malaria infection and identify distinctive
patterns that are characteristic of different disease states. Contrary
to other proteomic approaches, high-throughput plasma proteome
profiling enables simultaneous analysis of a large number of
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samples. Therefore plasma proteome profiling allows the use of
statistical pattern-recognition methods to discover and validate
proteome-patterns that discriminate disease states.
We hypothesized that the plasma proteome during malaria
infection reflects the molecules that are modulated as the severe
status is established. In the present study we show that distinctive
plasma proteome-patterns distinguish the different severe pre-
sentations of P. falciparum childhood malaria from the uncompli-
cated cases and also from well or unwell children without malaria.
Methods
Ethics Statement
Parents or guardians of study participants gave informed written
consent. This research was approved by the joint ethics committee
of the College of Medicine of the University of Ibadan and the
University College Hospital Ibadan.
Study Site
All study participants were recruited under the auspices of the
Childhood Malaria Research Group (CMRG) at the 600-bed
tertiary hospital University College Hospital (UCH) in the city of
Ibadan, Nigeria in west sub-Saharan Africa. Ibadan is a densely
populated urban setting with a population of 2.5 million
inhabitants. Ibadan has a lengthy 8 months rainy season from
March to October with malaria transmission and severe disease
present all year round (holoendemic).
The study site is located in the UCH Ibadan Department of
Paediatrics. We screen about 12,000 children attending the
hospital (ill and well) for malaria parasites per year. Our studies
report 11.3% SMA and 19.7% CM admissions in the parasitized
children under five years of age [9].
Study Design and Case Definitions
The participants in this study were recruited during 2006 to
2009 as part of a larger prospective case-control study of childhood
severe malaria currently ongoing under the auspices of the
CMRG. This case-control study was divided into a Discovery
Cohort consisting of those patients recruited during 2006 to 2008
and a Validation Cohort made up of those recruited in the 2008 to
2009 period.
Malaria parasites were detected and counted by microscopy
following Giemsa staining of thick and thin blood films [15].
Children with severe malaria were recruited on admission from
the Otunba Tunwase Children’s Emergency Ward (OTCHEW).
Children with uncomplicated malaria were recruited as part of
a daily routine malaria parasite screening at the Children’s Out-
patient Clinics (CHOP). Malaria-negative ill children were
recruited either at admission from OTCHEW or from the
Department of Paediatrics In-patient wards. Malaria-negative
healthy community control children were recruited from local
vaccination clinics as well as during school visits across several
Ibadan districts.
We recruited children aged from 6 months to 13 years using five
participant definitions. The malaria-positive children, the cases,
are Uncomplicated Malaria (UM), Severe Malarial Anemia (SMA)
and Cerebral Malaria (CM). The malaria-negative children, the
controls, are Disease Control (DC) and Community Controls
(CC). We followed the WHO criteria for severe P. falciparum
malaria [10]. Cerebral malaria cases were defined as children in
unrousable coma for at least one hour in the presence of asexual P.
falciparum parasitemia with normal cerebrospinal fluid. A Blantyre
coma score less than 2 was used to assess coma status. Children
with hypoglycemia were excluded from the study. Added to the
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strict clinical and laboratory definitions of CM, our study patients
recover consciousness after effective antimalarial therapy. We
excluded from this study those CM patients who died. Our overall
mortality rate for CM is of the order of 10%. Severe malarial
anemia cases were defined as conscious children with Packed Cell
Volume (PCV) less than 16% in the presence of P. falciparum
parasitemia. We excluded from this study those SMA patients who
died. Our overall mortality rate for SMA is less than 1%.
Uncomplicated malaria cases were defined as febrile children with
P. falciparum parasitemia who did not require hospital admission.
Figure 1. Discriminatory accuracy of proteome profiles across study groups. CM=Cerebral Malaria; SMA=Severe Malarial Anemia;
UM=Uncomplicated Malaria; DC=Disease Controls; CC=Community Controls. Blue bars compare (CM, SMA and UM) with non-parasitemic CC.
MP(2ve) =malaria parasite negative; MP(+ve) =malaria parasite positive. Green bar compares DC and CC (both non-parasitemic). Orange bars
compare (CM, SMA and UM) with DC (non-parasitemic). Yellow bars compare CM, SMA and UM (all parasitemic) among themselves. In brackets are
shown the number of relevant m/z clusters that make up the discriminatory proteome profile. (a.) Accuracy of predictive models built with relevant
m/z clusters using the discovery cohort data. Error bars indicate +/2 standard deviations obtained by 100 train/test randomizations of the data. (b.)
Accuracy of the best predictive model from (a.) when applied to the validation cohort data.
doi:10.1371/journal.pone.0049778.g001
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Our study was designed to discover and validate plasma proteome
changes in dichotomous cases for which we only included those
children with CM and UM with PCV greater than 20% (Table 1).
We excluded from the study blood culture positive cases. Although
we did not carry out blood cultures in all severe malaria patients,
the cases recruited into this study are those in whom septicemia
was not suspected and who were successfully treated with
antimalarial alone.
The DC group consists of malaria-negative children with
infectious diseases such as meningitis, otitis media, diarrhea and
upper respiratory tract infections. It also includes mild to
moderately anemic children and children admitted for surgery.
Clinical Data and Sample Collection
Participants’s clinical data were collected using a malaria-
tailored questionnaire designed by the CMRG. A 2.5 ml blood
sample was obtained from each participant in an EDTA blood
collection tube for subsequent plasma separation. Blood samples
were kept on ice and transferred to the central malaria laboratory.
Plasma for this study was harvested by centrifugation (1000 g, 10
Figure 2. Discriminatory performance of proteome profiles across study groups in ROC space. CM=Cerebral Malaria; SMA=Severe
Malarial Anemia; UM=Uncomplicated Malaria; DC=Disease Controls; CC=Community Controls. (a.) Discriminatory performance in ROC space of
predictive models built with relevant m/z clusters using the discovery cohort data. Error bars indicate +/2 standard deviations obtained by 100 train/
test randomizations of the data. (b.) Discriminatory performance in ROC space of the best predictive model from (a.) when applied to the validation
cohort data.
doi:10.1371/journal.pone.0049778.g002
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minutes), aliquoted and frozen at 280uC no later than 4 hours
following collection.
Clinical Laboratory Analysis
Packed cell volume (PCV) was measured using the micro-
haematocrit method [15]. Briefly, Blood was obtained in capillary
tubes. Tubes were centrifuged at 12,000 g for 5 minutes. The
percentage cell volume compared to the whole tube volume was
calculated (i.e. PCV). Mean (6 standard deviation, sd), minimum
and maximum PCV for each clinical group are tabulated in
Table 1. For discovery and validation cohort, these data were
compared using a one-way multiple ANOVA test (p,0.05).
Malaria parasites were detected and counted by microscopy
following Giemsa staining of thick and thin blood films [15].
Malaria Parasite (MP) densities were calculated as follows MP/
Figure 3. Visualization of community control (CC, non-parasitaemic) children versus other study groups. Each sphere represents an
individual child proteome profile plotted in 3D space defined by the first three principal components. CM=Cerebral Malaria (red); SMA=Severe
Malarial Anemia (purple); UM=Uncomplicated Malaria (yellow); DC=Disease Controls (blue); CC=Community Controls (green). (a.) CC vs. CM; (b.) CC
vs. SMA; (c.) CC vs UM and (d.) CC vs. DC.
doi:10.1371/journal.pone.0049778.g003
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mL= [(number malaria parasites/wbc) x 8,000] and expressed as
log(MP/mL) for each malaria-positive clinical group (Table 1). The
microscopic criterion for declaring a participant to be free of
malaria was the absence of parasites in 100 high-power (1000X)
fields. One in 10 thick blood films were randomly selected and
independently reviewed by local experienced microscopists not
part of the research team.
Solid-phase High-throughput Plasma Fractionation and
Proteomic Profiling
Crude plasma was profiled using Surface Enhanced Laser
Desorption/Ionization-Time Of Flight (SELDI-TOF) mass spec-
trometry. All plasma samples underwent two freeze-thaw cycles
prior to analysis. Plasma samples were coded, blinded and
randomized before application onto the following solid-phase
fractionation surfaces (ProteinChipH arrays Bio-Rad): weak-cation
exchange (CM10), strong-anion exchange (Q10) and reverse phase
(H50) as previously described [16]. Liquid handling steps were
automated using a Biomek 3000 Laboratory Automation Work-
station (Beckman Coulter) and a 96 well BioprocessorH (Bio-Rad).
Each ProteinChipH 96 well BioprocessorH included 1 quality
control plasma standard derived from a single healthy individual,
placed at random. Mass spectra were generated on a System 4000
Bio-Rad ProteinChipH mass spectrometer. Spectral peaks corre-
sponding to mass/charge (m/z) clusters were detected and
clustered using ProteinChipH Datamanager Client 4.1 software
(BioRad). Mass spectrometer calibration was performed using All-
in-1 Peptide and Protein calibrants (Bio-Rad). Reproducibility was
determined by measuring the inter-ProteinChipH coefficient of
variation (CV) for the quality control spectra, based on all peaks in
the spectrum with intensity .1 mA. Overall interchip CV for the
quality control sample was 20%, consistent with similar studies.
Liquid-phase High-throughput Anionic Exchange Plasma
Fractionation
Liquid-phase anion-exchange fractionation of plasma samples
was carried out using the ProteinChipH Fractionation Kit (Bio-
Rad) according to the manufacturer’s instructions with a Biomek
3000 Laboratory Automation Workstation. Six fractions were
obtained from each sample eluting at pH 9.0 (f1), pH 7.0 (f2),
pH 5.0 (f3), pH 4.0 (f4), pH 3.0 (f5) and organic phase (f6).
Data Analysis
We selected subsets of the most relevant mass clusters in the
discovery cohort groups using the weighted Kernel-based Iterative
Estimation of Relevance Algorithm [17] (wKIERA) that combines
a stochastic-search estimation of distribution algorithm with
a kernel pattern-recognition method. We then used discovered
relevant subsets of mass clusters to build discriminatory predictive
models. We adopted a supervised learning approach to derive
a classification rule using the Support Vector Machine (SVM)
method [18]. Briefly, we used 10-fold cross validation to select
parameters for the SVM. For the final model parameters, we
selected those that gave the overall highest accuracy across the
whole 10-fold cross validation. To obtain robust accuracy
estimates for the classifier on the discovery data, we took 100
random re-samplings of the data, using 80% for training and 20%
for testing. We selected as a final classifier the one that produced
the highest accuracy and was then tested on the validation cohort
data. Results were expressed as sensitivity, specificity and accuracy
(proportion of correct classifications) and plotted on Receiver
Operator Characteristic (ROC) space plots.
Our multivariate statistical tests included testing against age or
sex to ascertain that significant pattern changes in the proteome
were not dependent on those variables in the population studied.
To visualize the covariance within the mass spectral profiles we
used Principal Component Analysis (PCA). PCA encapsulates the
covariance within a set of variables by extracting a ranked set of
independent factors or principal components. The first 3
components encompass a high proportion (,95%) of the
informational content of a multivariate dataset. We plotted each
patient with respect to the first 3 components, in 3-dimensional
space, color-coding according to patient group.
Results
Study Participants
A total of 946 children participated in this study as part of the
discovery and validation case-controlled cohorts. The discovery
cohort comprised of 367 malaria-positive children with either
Cerebral Malaria (CM), Severe Malarial Anemia (SMA) or
Uncomplicated Malaria (UM), and 289 malaria-negative children
who were either Disease Controls (DC) or Community Controls
(CC) (Table 1). The validation cohort was prospectively recruited
after the discovery cohort and comprised 160 malaria-positive
children with either CM, SMA or UM, and 130 malaria-negative
DC or CC children (Table 1). PCV and malaria parasite (MP)
densities are presented in Table 1. Consistent with the recruitment
criteria, both discovery and validation SMA groups had PCVs
below 16% (Table 1). There was mild anemia across CM, UM and
DC groups in both cohorts, whereas CC had normal mean
hematocrit (Table 1). Parasite densities across all the infected
groups were similar (Table 1).
Plasma Proteome-patterns Define the Major childhood
Malaria Syndromes
To compare the proteome-patterns of the study groups, we
fractionated plasma samples by three different chromatography
procedures on solid-phase surfaces (weak-cationic and strong-
anionic ion-exchange, and reverse-phase) followed by Time-Of-
Flight mass spectrometry. The resulting mass spectra from each of
the surfaces contained a series of mass/charge ratio (m/z) peak
clusters, each representing a protein of a particular mass. A set of
proteins that are present, absent or at a different level in the
samples defines a proteome-pattern that may discriminate between
two or more of the study groups. To discover such patterns we
applied statistical pattern recognition algorithms to the profiles and
the selected number of discriminating proteins for each of the
pairwise group comparisons is shown in Figure 1, as the numbers
in parentheses (Data S1). We built predictive models with the
selected proteome-pattern for each study group comparison using
a non-parametric supervised learning statistical framework. The
discriminatory accuracy of these predictive models in the discovery
cohort groups is shown in Figure 1a. To determine differences for
malaria-positive children from healthy malaria-negative children
Figure 4. Visualization of (a-c) disease control (DC, non-parasitemic) children versus parasitemic children groups; (d-f) among CM,
SMA and UM parasitaemic children groups. Each sphere represents an individual child proteome profile plotted in 3D space defined by the first
three principal components. CM=Cerebral Malaria (red); SMA= Severe Malarial Anemia (purple); UM=Uncomplicated Malaria (yellow); DC=Disease
Controls (blue). (a.) DC vs. CM; (b.) DC vs. SMA; (c.) DC vs. UM; (d.) CM vs. SMA; (e.) CM vs. UM and (f.) SMA vs. UM.
doi:10.1371/journal.pone.0049778.g004
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we compared individually the plasma proteome of CM, SMA and
UM groups with that of the CC group.
Overall, 22 to 33 proteins composed the discriminatory patterns
with accuracies above 90% across the three comparisons
(Figure 1a, blue bars). Twenty-six proteins discriminated healthy
from ill (hospital admitted) malaria-negative children (CC vs. DC)
with similar accuracy (Figure 1a, green bar). To examine proteins
that are specific to malaria infection we compared each of the
malaria-positive groups (CM, SMA, UM) to the DC group,
obtaining discrimination accuracies above 80% (Figure 1a. orange
bars). Finally, to assess differences between defined malaria
syndromes we compared the malaria-positive groups (Figure 1a.
yellow bars). In the comparison between CM and SMA, the two
major severe syndromes, the accuracy was 70% (24 proteins).
Higher accuracies between 70 to 80% were observed when
samples from either CM or SMA groups were compared to UM
children, using 36 and 54 proteins, respectively.
To validate the accuracy of the discrimination for the
discovered plasma proteome-patterns, we tested the predictive
models on the validation cohort groups (Figure 1b). The best
predictive model for each group comparison in the discovery
cohort was asked to predict the group class in the validation
cohort. We found that the predictive models obtained using the
discovery cohort had similar accuracy for discrimination in the
different group comparisons for the validation cohort (Figure 1b).
We compared the sensitivity and specificity of the predictive
models for both discovery and validation cohort groups in ROC
space and found them to be similar (Figure 2).
We then used Principal Component Analysis (PCA) on the
selected proteins to visualize the separation of patient groups. The
CC group clustered tightly together (Figure 3, green spheres).
Individual malaria-positive groups showed good separation from
the malaria-negative CC group (Figure 3a–c) indicating that
regardless of disease severity there are significant differences in the
proteomes of the groups. The heterogeneous DC group had
a more dispersed cluster pattern with little overlap with the CC
group (Figure 3d). The DC group, despite being distinct, showed
different degrees of overlap with the malaria-positive groups
(Figure 4a–c). Of these comparisons, the CM vs. DC patient
groups showed the greatest level of cluster dispersion (Figure 4a)
indicating greater covariance in the proteins that define these
groups. We then compared the malaria-positive patient groups
among themselves (Figure 4d–f). CM and SMA groups showed
overlap at the cluster interface and clearer segregation at the
periphery; in the comparison of both severe forms (CM and SMA)
with UM we observed that the severe patient groups had compact
center clusters surrounded by a more disperse cluster of the UM
patient group.
Reduction of Plasma Proteome Complexity Provides
Further Discriminatory Proteins for Severe Childhood
Malaria
We simplified further the complexity of the plasma proteome by
high-throughput liquid-phase anion-exchange fractionation fol-
lowed by solid-phase weak-cation exchange fractionation prior to
protein mass determination in the spectrometer on a subset of the
samples. We assessed the discriminatory accuracy of relevant
proteins obtained from each of the six anion-exchange fractions
(Figure 5, f1 to f6) (Data S2). The reduction in the complexity of
Figure 5. Discriminatory accuracy of proteome profiles across
six anionic plasma fractions (f1 to f6) among CM, SMA and UM
(all parasitemic) groups of children. CM= Cerebral Malaria;
SMA= Severe Malarial Anemia; UM=Uncomplicated Malaria. f1 to f6
represent anionic plasma fractions at pH 9.0 (f1), pH 7.0 (f2), pH 5.0 (f3),
pH 4.0 (f4), pH 3.0 (f5) and organic phase (f6). In brackets are shown the
number of relevant m/z clusters that make up the discriminatory
proteome profile. (a.) CM vs. SMA; (b.) CM vs. UM; (c.) SMA vs. UM.
doi:10.1371/journal.pone.0049778.g005
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Figure 6. Proteome-pattern overlap. The Venn diagram represents the level of overlap between the patterns that individually discriminate CM,
SMA, UM and DC from CC. CM=Cerebral Malaria; SMA= Severe Malarial Anemia; UM=Uncomplicated Malaria. f1 to f6 represent anionic plasma
fractions at pH 9.0 (f1), pH 7.0 (f2), pH 5.0 (f3), pH 4.0 (f4), pH 3.0 (f5) and organic phase (f6).
doi:10.1371/journal.pone.0049778.g006
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each fraction of the plasma samples resulted in a larger subset of
proteins that improved discrimination between the malaria
syndromes. Sets of proteins that distinguish between SMA and
CM groups (Figure 5a, f1 to f6 in brackets) slightly outperformed
the proteome-pattern from non-fractionated plasma. Sets of
proteins differentiated the CM and UM groups with accuracies
ranging from 70 to 80% (Figure 5b, f1 to f6 in brackets) and
distinguished between SMA and UM with comparable accuracy
(Figure 5c, f1 to f6 in brackets).
We carried out an overall analysis of plasma proteome pattern
overlap by comparing the discovered sets of proteins that
discriminate UM, CM, SMA (malaria-positive) and DC (ma-
laria-negative) ill children from the malaria-negative well children
CC (Figure 6, f1 to f6). We show that each plasma fraction (f1 to
f6) contains a set of proteins that clearly define both the malaria-
positive and malaria-negative ill children to those malaria-negative
well children in the community. Furthermore, we also show that
the set of proteins that discriminate SMA and CM from UM have
very little overlap across the six plasma fractions (Figure 6, f1 to
f6).
Discussion
In the present study we carried out a large case-control study of
severe childhood malaria, using a discovery cohort to define
discriminatory plasma proteome-patterns and a second cohort to
validate our findings, at the main tertiary hospital of the city of
Ibadan, Nigeria.
We show that proteome-patterns from both crude and pre-
fractionated plasma samples accurately define childhood malaria
syndromes in the discovery cohort. We confirmed these findings
using a prospectively collected validation cohort. Malaria infection
introduces distinguishable changes in the plasma proteome of
children as seen by the striking differences between the malaria-
negative CC and the malaria-positive children groups. The plasma
proteome differences are specific for the malaria disease process
and not surrogate markers of acute illness, as we are able to
accurately distinguish between malaria-negative ill children and
malaria-positive groups independently of their disease severity. We
have also discovered plasma proteome differences that are specific
to each of the childhood malaria syndromes assessed in the present
study. Our findings provide a starting point to refine the current
WHO definitions of these syndromes, which lack the necessary
specificity to further study severe malaria pathogenesis.
We show that assessing the plasma proteome of the major
malaria syndromes provides an unbiased discovery of combination
of proteins that could be used to deepen our understanding of the
pathogenesis of childhood malaria. This is supported by the
finding that we can discriminate children with uncomplicated
malaria from those with severe malarial anemia or cerebral
malaria in both discovery and validation cohorts. These proteome-
patterns encapsulate what changes differentiate uncomplicated
malaria from the severe cases.
Overall, accuracy of discrimination between the CM and SMA
was lower than that in the comparison of each of these syndromes
with the UM group. The degree of overlap between CM and SMA
goes beyond that expected from strict application of the WHO
case definitions used in this study. Nevertheless, the plasma
proteome-pattern discriminated with over 70% accuracy between
the severe groups. This suggests that beyond common underlying
mechanisms, such as acute inflammation, there are significant
differences in the pathogenesis of the severe syndromes studied.
Our large cohorts allowed us to statistically validate the pattern-
based proteome definitions of the major childhood malaria
syndromes. Although the mass spectrometry platform used in
our study does not provide direct molecular identification, the
chromatographic chemistry used and the mass-to-charge (m/z)
ratio can be exploited to guide the identification of the set of
proteins relevant for discrimination between syndromes. Plasma
proteome profiling has been used to define a variety of disease
states[16,19–24] as there is growing recognition of the advantages
of using ‘omics’-based methods to achieve sufficient levels of
accuracy [24]. Our study showed that complex plasma protein
patterns were necessary to discriminate between the different
malaria syndromes. This further underlines the advantage of using
unbiased high-throughput pattern recognition based methods.
In many infectious diseases, there are clinically important
distinctions to be made between different manifestations associated
with the same underlying pathogen and malaria clinical
syndromes are a clear case in point. The pathogenesis of malaria
due to its erythrocytic cycle occurs in the cardiovascular system
and it is plausible that proteome changes in organs such as brain,
spleen, kidney and bone marrow can be reflected in the plasma
proteome. Our study confirms that there are proteome changes
characteristic of the clinical malarial syndromes with different level
of accuracy. Furthermore, host modulation by the pathogen is
likely to generate changing patterns of protein expression
associated with the progression of severe malaria syndromes and
our current studies are designed to address such changes.
The lack of specific childhood malaria definitions has limited
the progress on understanding the pathology of the major severe
syndromes. To the best of our knowledge this study is the first to
show that a panel of proteins, defined as a proteome-pattern,
dissects clinical malaria syndromes. Further identification of the
proteins that comprise the proteome-patterns will provide hints to
the underlying pathogenesis on each of the syndromes. Further-
more, these proteome-patterns provide a reference point to
facilitate the identification of other complex and overlapping
severe childhood malaria syndromes.
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